Clinical Research
Global

Clinical Research Experts

Christophe Arbet-engels

Chief Medical Officer, Executive Vice President
Development & Medical Affairs
Aptar Group
France

Biography

Dr. Arbet-Engels has more than 25 years of experience in life sciences, academia and industry. Dr. Arbet-Engels’ leadership at several large pharmaceutical companies encompasses clinical development and registration, launch and lifecycle management for several innovative drugs for the treatment of diabetes, metabolism and cardiovascular diseases, including Lantus® (insulin glargine) and Jardiance® (empagliflozin). Most recently, he was Vice President, Worldwide Medical, Collaborative Medical Sciences at Biogen, driving strategy and execution of Phase 3b/4 life cycle management activities. Prior to Biogen, Dr. Arbet-Engels worked in senior leadership positions in clinical development and medical affairs at pharmaceutical and biotech companies, including Boehringer Ingelheim, Roche, Merck, Aventis (now Sanofi) and Ligand Pharmaceuticals. In addition, Dr. Arbet-Engels served as a Medical Advisor to MedNest, provided expertise to the Gerson Lehrman Group, and worked as French Foreign Trade Advisor for the French Government to advise and support French or other startup companies develop their business in the U.S. Dr. Arbet-Engels has a medical degree from University of Paris Sud, a PhD in endocrinology/diabetes and metabolism from Paris Descartes University and a master’s degree in business administration from Rutgers University.

Research Interest

biopharmaceutical and endocrinology/diabetes and metabolism

Global Experts from France

Global Experts in Subject